文献速递免疫规划传染病防控与疫情报告

表达DHAV-3 VP1蛋白的重组乳酸乳球菌口服疫苗诱导黏膜与全身免疫应答

Oral vaccine of recombinant Lactococcus lactis expressing the VP1 protein of duck hepatitis A virus type 3 induces mucosal and systemic immune responses.
PubMed 文献 · Vaccine · 2019-06-18

本研究构建了表达鸭甲肝病毒3型(DHAV-3)VP1蛋白的重组乳酸乳球菌NZ3900-VP1,并在小鼠和雏鸭中评估口服免疫效果。结果显示该疫苗显著诱导抗VP1 IgG、黏膜sIgA及细胞因子应答,雏鸭在自然感染DHAV-3时获得有效保护。

要点

  • 重组乳酸乳球菌NZ3900-VP1可经nisin诱导表达DHAV-3 VP1蛋白。
  • 口服免疫诱导小鼠和雏鸭产生抗VP1 IgG及黏膜sIgA。
  • 免疫雏鸭面对DHAV-3自然感染获得有效保护。

核心结论

  • 重组乳酸乳球菌NZ3900-VP1口服疫苗可诱导针对DHAV-3的黏膜和全身免疫应答,并对雏鸭提供有效保护。

研究设计与样本

  • 构建表达DHAV-3 VP1蛋白的重组乳酸乳球菌NZ3900-VP1,采用nisin控制表达系统,并在小鼠和雏鸭中进行口服免疫动物实验。

主要发现

  • 口服免疫重组菌NZ3900-VP1显著诱导小鼠和雏鸭产生抗VP1 IgG抗体及DHAV-3黏膜sIgA。
  • 免疫后细胞因子IL-2、IFN-γ、IL-10和IL-4被诱导产生。
  • 免疫雏鸭在自然感染DHAV-3时得到有效保护。

临床怎么用

  • 该重组乳酸乳球菌可作为候选口服疫苗用于预防雏鸭DHAV-3感染。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Duck hepatitis A virus (DHAV) is the major pathogen of duck viral hepatitis, which has caused great economic losses to duck breeding industry. As an effective delivery tool for protein antigens, Lactococcus lactis (L. lactis) has been successfully used to stimulate mucosal and systemic immune response. In this study, a recombinant L. lactis named NZ3900-VP1 was constructed, which could express VP1 protein of DHAV type 3 (DHAV-3) by using a nisin-controlled expression (NICE) system. The animal experiment in both mice and ducklings were performed to detect the immune response and protection effect of oral vaccination by the recombinant L. lactis. The results showed that oral vaccination with L. lactis NZ3900-VP1 significantly induced specific anti-VP1 IgG antibodies and mucosal secretory immunoglobulin A (sIgA) of DHAV-3 in mice and ducklings, and cytokines including interleukin-2 (IL-2), interferon gamma (IFN-γ), interleukin-10 (IL-10) and interleukin-4 (IL-4). Notably, the ducklings vaccinated with L. lactis NZ3900-VP1 were effectively protected when facing natural infestation of DHAV-3, which indicated that the recombinant L. lactis could serve as an effective vaccine to prevent DHAV-3 infection in ducklings.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Song S, Li P, Zhang R, et al. Oral vaccine of recombinant Lactococcus lactis expressing the VP1 protein of duck hepatitis A virus type 3 induces mucosal and systemic immune responses. Vaccine. 2019. PMID: 31227355. doi:10.1016/j.vaccine.2019.06.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。